CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis Via the AKT Pathway in Hepatocellular Carcinoma

Overview

Journal J Cancer

Specialty Oncology

Date 2019 Jun 18

PMID 31205541

Citations 37

Authors

Hao Chen

Jun Chen

Long Zhao

Wenfeng Song

Zefeng Xuan

Jian Chen

Zequn Li

GuangYuan Song

Liangjie Hong

Penghong Song

Shusen Zheng

Affiliations

Soon will be listed here.

Abstract

Cell division cycle associated 5 (CDCA5) is an important element for the interaction between cohesin and chromatin in interphase. It is abnormally expressed in many types of cancer and works as an indicator of poor prognosis, but little is known about its activity in hepatocellular carcinoma (HCC). In the present study, we found that the expression of CDCA5 was upregulated in HCC tissues compared to paracancerous tissues and had a negative correlation with patient survival. Cell proliferation and tumorigenesis were inhibited and cell apoptosis was induced with the knockdown of CDCA5, suggesting an oncogenic role of CDCA5 in liver cancer. Luciferase reporter assay and chromatin immunoprecipitation showed that CDCA5 was transcribed by E2F1. Furthermore, we confirmed that CDCA5 interrupted cell behavior via the AKT pathway. These findings demonstrated that CDCA5 plays an important role in HCC progression.

Citing Articles

E2F1-Dependent CDCA5 overexpression drives cervical cancer progression and correlates with poor prognosis.

Wang Y, Zhang W, Peng M J Mol Histol. 2025; 56(2):80.

PMID: 39907709 DOI: 10.1007/s10735-025-10356-z.

Identification of SNPs and Candidate Genes Associated with Monocyte/Lymphocyte Ratio and Neutrophil/Lymphocyte Ratio in Duroc × Erhualian F Population.

Qiao J, Xu M, Xu F, Che Z, Han P, Dai X Int J Mol Sci. 2024; 25(17).

PMID: 39273692 PMC: 11396299. DOI: 10.3390/ijms25179745.

Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma.

Singh V, Pathak S, Kumar N, Jayandharan G ACS Omega. 2024; 9(28):30945-30953.

PMID: 39035883 PMC: 11256310. DOI: 10.1021/acsomega.4c03949.

CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.

Xiong Y, Shi L, Li L, Yang W, Zhang H, Zhao X J Transl Med. 2024; 22(1):639.

PMID: 38978058 PMC: 11232132. DOI: 10.1186/s12967-024-05443-w.

Finding key genes (UBE2T, KIF4A, CDCA3, and CDCA5) co-expressed in hepatitis, cirrhosis and hepatocellular carcinoma based on multiple bioinformatics techniques.

Zhang Y, Yu W, Zhou S, Xiao J, Zhang X, Yang H BMC Gastroenterol. 2024; 24(1):205.

PMID: 38890649 PMC: 11184838. DOI: 10.1186/s12876-024-03288-7.

References

Rankin S, Ayad N, Kirschner M . Sororin, a substrate of the anaphase-promoting complex, is required for sister chromatid cohesion in vertebrates. Mol Cell. 2005; 18(2):185-200. DOI: 10.1016/j.molcel.2005.03.017. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Liao Y, Hung M . Physiological regulation of Akt activity and stability. Am J Transl Res. 2010; 2(1):19-42. PMC: 2826820. View

Lee H, Park I, Park M, An S, Woo S, Jin H . Sulindac and its metabolites inhibit invasion of glioblastoma cells via down-regulation of Akt/PKB and MMP-2. J Cell Biochem. 2004; 94(3):597-610. DOI: 10.1002/jcb.20312. View

Lu Z, Bauzon F, Fu H, Cui J, Zhao H, Nakayama K . Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity. Nat Commun. 2014; 5:3463. PMC: 3982150. DOI: 10.1038/ncomms4463. View

Huang Y, Tai A, Tong S, Lok A . HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. J Hepatol. 2013; 58(6):1068-73. PMC: 3898818. DOI: 10.1016/j.jhep.2013.01.014. View

Dominguez-Brauer C, Thu K, Mason J, Blaser H, Bray M, Mak T . Targeting Mitosis in Cancer: Emerging Strategies. Mol Cell. 2015; 60(4):524-36. DOI: 10.1016/j.molcel.2015.11.006. View

Wang B, Hsu S, Wang X, Kutay H, Bid H, Yu J . Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Hepatology. 2013; 59(2):555-66. PMC: 4199239. DOI: 10.1002/hep.26712. View

10.

Lin A, Piao H, Zhuang L, Sarbassov D, Ma L, Gan B . FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway. Cancer Res. 2014; 74(6):1682-93. PMC: 4087030. DOI: 10.1158/0008-5472.CAN-13-1729. View

11.

Kato T, Lee D, Wu L, Patel P, Young A, Wada H . SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma. Int J Oncol. 2016; 49(6):2411-2420. DOI: 10.3892/ijo.2016.3765. View

12.

Santoni-Rugiu E, Duro D, Farkas T, Mathiasen I, Jaattela M, Bartek J . E2F activity is essential for survival of Myc-overexpressing human cancer cells. Oncogene. 2002; 21(42):6498-509. DOI: 10.1038/sj.onc.1205828. View

13.

Ladu S, Calvisi D, Conner E, Farina M, Factor V, Thorgeirsson S . E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology. 2008; 135(4):1322-32. PMC: 2614075. DOI: 10.1053/j.gastro.2008.07.012. View

14.

Li J, Dokka S, Wang L, Shi X, Castranova V, Yan Y . Activation of aPKC is required for vanadate-induced phosphorylation of protein kinase B (Akt), but not p70S6k in mouse epidermal JB6 cells. Mol Cell Biochem. 2004; 255(1-2):217-25. DOI: 10.1023/b:mcbi.0000007277.90298.24. View

15.

Tin Chua B, Gallego-Ortega D, Ramirez de Molina A, Ullrich A, Lacal J, Downward J . Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells. Mol Cancer. 2010; 8:131. PMC: 2806310. DOI: 10.1186/1476-4598-8-131. View

16.

Chen D, Pacal M, Wenzel P, Knoepfler P, Leone G, Bremner R . Division and apoptosis of E2f-deficient retinal progenitors. Nature. 2009; 462(7275):925-9. PMC: 2813224. DOI: 10.1038/nature08544. View

17.

Huang C, Yuan Y, Wu D, Khan F, Jiao X, Huo L . The cohesion stabilizer sororin favors DNA repair and chromosome segregation during mouse oocyte meiosis. In Vitro Cell Dev Biol Anim. 2016; 53(3):258-264. DOI: 10.1007/s11626-016-0107-0. View

18.

Qin X, Livingston D, Kaelin Jr W, Adams P . Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A. 1994; 91(23):10918-22. PMC: 45137. DOI: 10.1073/pnas.91.23.10918. View

19.

Tokuzen N, Nakashiro K, Tanaka H, Iwamoto K, Hamakawa H . Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma. Oncotarget. 2015; 7(3):2343-53. PMC: 4823039. DOI: 10.18632/oncotarget.6148. View

20.

Brunet A, Bonni A, Zigmond M, Lin M, Juo P, Hu L . Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999; 96(6):857-68. DOI: 10.1016/s0092-8674(00)80595-4. View